Vincenzo Federico
Lecce, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Fludarabine-Treosulfan (FT10) Conditioning in Older AML Patients Undergoing Haploidentical Transplantation: A Prospective Italian Study With External Comparison to the Haplo-UK Reduced-Intensity Conditioning Cohort.
Journal: Transplantation and cellular therapy
Published: April 02, 2026
Real-world approaches to preventing acute myeloid leukemia relapse after allogeneic transplantation: a national survey by GITMO (Gruppo Italiano Trapianto Midollo Osseo).
Journal: Bone marrow transplantation
Published: April 01, 2026
Association of hypomethylating agents + venetoclax in the real-life treatment of Myeloproliferative Neoplasms in blastic phase.
Journal: Leukemia research
Published: March 06, 2026
Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinib.
Journal: Haematologica
Published: January 14, 2026
NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON Cohort.
Journal: Hematological oncology
Published: November 10, 2025
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMT.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: October 25, 2025
Hypomethylating agents alone or in combination with venetoclax in very elderly acute myeloid leukemia patients: less treatment, better care?
Journal: Annals of hematology
Published: October 22, 2025
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study.
Journal: American journal of hematology
Published: August 22, 2025
Effectiveness of Gilteritinib Beyond Second-Line Therapy in Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia: A Real-World Multicenter Study of 171 Patients.
Journal: American journal of hematology
Published: August 08, 2025
Treosulfan-based double-alkylator conditioning in myelofibrosis: An Italian retrospective multicenter analysis.
Journal: Bone marrow transplantation
Published: August 04, 2025
Venetoclax plus hypomethylating agents as effective bridge therapy to allogeneic stem cell transplant in relapsed/refractory acute myeloid leukaemia: A subanalysis of the AVALON study.
Journal: British journal of haematology
Published: July 29, 2025
Single versus double autologous stem cell transplantation and lenalidomide maintenance versus no maintenance therapy in newly-diagnosed patients with multiple myeloma: a real-life, vintage snapshot after twenty-three years from the Rete Ematologica Pugliese.
Journal: Annals of hematology
Published: July 19, 2025
Last Updated: 09/26/2026